Related Experiment Video
Updated: Mar 12, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
High Prevalence of Diastolic Dysfunction in Incident Patients on Peritoneal Dialysis: Association with Low Thyroid
Virginia Sánchez1, Ramón Paniagua, Maria Del Carmen Prado
1Unidad de Investigación Médica en Enfermedades Nefrológicas, Hospital de Especialidades, CMN, SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Insights
Diastolic dysfunction (DD) is common in peritoneal dialysis (PD) patients. Low triiodothyronine (T3) levels are an independent risk factor for severe DD, suggesting a link between thyroid hormones and cardiac health in kidney disease.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Diastolic dysfunction (DD) and low thyroid hormones (TH) are prevalent in chronic kidney disease (CKD) and linked to mortality.
- The relationship between DD and TH in CKD patients on peritoneal dialysis (PD) remains unclear.
Purpose of the Study:
- To investigate DD as a potential marker of fibrosis.
- To analyze the association between DD and TH levels in incident PD patients.
Main Methods:
- Cross-sectional study of 183 incident PD patients with preserved ejection fraction.
- Assessed serum total and free triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone.
- Evaluated left ventricular (LV) mass and DD using echocardiography and tissue Doppler imaging.
Main Results:
- 62% of patients exhibited some degree of DD, with 36% having grade III DD.
- Grade III DD was associated with diabetes mellitus (DM), older age, high LV mass, and lower T3/T4 levels.
- Logistic regression identified DM, hypertension, and total T3 (tT3) as independent risk factors for grade III DD.
Conclusions:
- A high prevalence of grade III DD was observed in incident PD patients.
- Total T3 emerged as an independent risk factor for severe DD, alongside DM and hypertension.
- Further research is warranted to elucidate the underlying mechanisms of this association.
Background/Aims:
Diastolic dysfunction (DD) and low levels of thyroid hormones (TH) are frequent found in chronic kidney disease; both are associated with all-cause and cardiovascular mortality. However, a link between them has not yet been established. The aim of this study was to analyze DD as a surrogate marker of fibrosis and its association with TH in incident patients on peritoneal dialysis (PD).
Methods:
A cross-sectional study with 183 incident patients on PD with preserved ejection fraction was performed. Clinical and demographic data were registered. Serum total and free (t/f) triiodothyronine (T3), thyroxin (T4), and thyroid stimulating hormone levels were determined by RIA kits, albumin and high-sensitivity C-reactive protein by conventional assays. Transthoracic 2D echocardiogram was performed for evaluation of left ventricular (LV) mass and ejection fraction. DD was evaluated using pulsed-wave tissue Doppler imaging.
Results:
Patients were 43 ± 12, 42% with diabetes mellitus (DM). Some degree of DD was found in 62% of patients; 18% had grade I DD, 8% grade II DD and 36% grade III DD. Patients with grade III DD were more likely to have diabetes, older, high LV mass and low serum albumin, t/fT3 and tT4 levels. In logistic multivariate regression analysis, it was found that diabetes (B = -0.86, 95% CI 0.182-0.992, p < 0.05), hypertension (B = -0.95, 95% CI 0.184-0.817, p = 0.01) and tT3 (B = -1.94, 95% CI 0.023-0.876, p < 0.05) were associated with grade III DD.
Conclusions:
High prevalence of grade III DD was found in incident patients on PD. In addition to DM and hypertension, tT3 was found to be an independent risk factor for grade III DD and more studies are needed to understand the reasons as to why this association is present.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis I: Introduction and Procedure
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure VI: Adjunct Therapies

